Nitrogen Use Efficient Rice Demonstrates an Average Yield Increase of 30 Percent in Four Years of Field Trials
-- Major Yield Increase Has the Potential to Change the Economics of Rice Production and Enhance Food Security --
In this most recent field trial under irrigated upland conditions and 50 percent of normal nitrogen fertilizer application, the leading NUE rice line out-yielded the conventional control lines by 34 percent. In the three previous years of trials under both irrigated lowland and upland rainfed conditions, the leading line out-yielded control lines by 22, 30 and 33 percent, respectively.
Over the four years of field trials, the average yield increase for the
leading NUE rice line was 30 percent over the conventional controls. In
the fourth-year trial, two additional NUE rice lines increased grain
yield by 24 to 28 percent at 17 percent of normally applied nitrogen
“Yield increases greater than 15 percent from a single trait are very
rare in agriculture,” said
“Yield increases of this magnitude have the potential to significantly change the economics of rice production, benefitting farmers, rural economies and food security simultaneously,” Rey added. “Together with our seed company partners, Arcadia is working diligently to bring commercial seed with our NUE trait to farmers in rice and several other major crops.”
Arcadia currently has five NUE products, including NUE rice, in Phase 3
of product development. The company recently completed the
Rice is the world’s most valuable crop, grown on 165 million hectares
globally with a harvest value of
Arcadia’s NUE trait was developed to help farmers increase crop yields per unit of applied nitrogen fertilizer. Nitrogen fertilizer is a key input to the global agricultural industry for increasing crop yield, but conventional crops typically utilize less than half of nitrogen fertilizer applied. Much of the remainder moves through the soil and enters ground and surface water systems, or volatilizes into the air as a greenhouse gas 300 times more potent than carbon dioxide. Arcadia’s NUE trait enables plants to produce higher yields while reducing the environmental footprint of agriculture.
The NUE rice field trials in
CIAT is an international agricultural research organization focused on eco-efficient agriculture that is, farming systems that better harness the available resources to be more competitive and to sustainably increase productivity, while leaving a smaller environmental footprint. CIAT significantly contributes to major global initiatives that seek to reduce rural poverty, strengthen food security, improve human health and nutrition, and sustainably manage natural resources throughout the developing world. For more information, visit www.ciatnews.cgiar.org.
USAID is the lead
About Feed the Future
Feed the Future is the U.S. Government’s global hunger and food security initiative. With a focus on smallholder farmers, particularly women, Feed the Future supports partner countries in developing their agriculture sectors to spur economic growth and trade that increase incomes and reduce hunger, poverty and under nutrition. For more information, visit www.feedthefuture.gov.
Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995,
including statements relating to Arcadia’s NUE trait and the regulatory
process for such trait. Forward-looking statements are subject to risks
and uncertainties that could cause actual results to differ materially,
and reported results should not be considered as an indication of future
performance. These risks and uncertainties include, but are not limited
to: Arcadia’s and its partners’ ability to develop commercial products
incorporating its traits, including the NUE trait, and complete the
regulatory review process for such products; Arcadia’s compliance with
laws and regulations that impact the company’s business, and changes to
such laws and regulations; Arcadia’s future capital requirements and
ability to satisfy its capital needs; and the other risks set forth in
Arcadia’s filings with the
Arcadia Biosciences, Inc.